The Health Impact Fund: A Useful Supplement to the Patent System?
Author:
- 21 May 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Public Health Ethics
- Vol. 1 (2) , 124-133
Abstract
The Health Impact Fund has been proposed as an optional, comprehensive advance market commitment system offering financial payments or ‘prizes’ to patentees of new drugs, which are sold globally at an administered low price. The Fund is designed to offer payments based on the therapeutic impact of the drugs or vaccines, so that innovators will have efficient incentives to develop drugs that maximize health gains. Consumers would have improved access to such drugs because of low prices.Keywords
This publication has 4 references indexed in Scilit:
- Incentivizing Access and Innovation for Essential Medicines: A Survey of the Problem and Proposed SolutionsPublic Health Ethics, 2008
- A Full-Pull Program for the Provision of Pharmaceuticals: Practical IssuesPublic Health Ethics, 2008
- Three Proposals for Rewarding Novel Health Technologies Benefiting People Living in Poverty. A Comparative Analysis of Prize Funds, Health Impact Funds and a Cost-Effectiveness/Competitive Tender TreatyPublic Health Ethics, 2008
- HUMAN RIGHTS AND GLOBAL HEALTH: A RESEARCH PROGRAMMetaphilosophy, 2005